Actively Recruiting
Study of Immune Responses to Influenza Vaccination
Led by University of Pennsylvania · Updated on 2025-08-19
75
Participants Needed
1
Research Sites
453 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Better understanding of the immune responses to influenza vaccination is needed in order to understand situations of poor vaccine response. Adults will receive influenza vaccination and then have peripheral blood drawn at pre-defined intervals in order to study the lymphocyte responses.
CONDITIONS
Official Title
Study of Immune Responses to Influenza Vaccination
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults living in the community who can provide consent
- Need influenza vaccination as part of standard care
You will not qualify if you...
- Having a fever or febrile illness at the time of vaccination
- Active cancer or malignancy
- Use of immunosuppressing medications
- Donated blood in the past 60 days
- Received influenza vaccination in the past 6 months
- History of allergic reaction to influenza vaccination
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
Research Team
S
Sokratis Apostolidis, MD
CONTACT
E
E.John Wherry, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here